The Hello Bar is a simple web toolbar that engages users and communicates a call to action.

February 4, 2012

Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas® in Europe and Canada

ZURICH & WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with [...]

Merck Receives European Approval for ELONVA(R)

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection).  ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology program. With the [...]

© Rx Times, LLC 2011. All rights reserved. All products denoted with ™ and ® are trademarks or registered trademarks of Rx Times, LLC and/or its affiliates.